<?xml version="1.0" encoding="UTF-8"?>
<records>
<record>
<language>eng</language>
<publisher>Science and Education Publishing</publisher>
<journalTitle>American Journal of Medical Case Reports</journalTitle>
<eissn>2374-216X</eissn>
<publicationDate>2020-11-12</publicationDate>
<volume>9</volume>
<issue>1</issue>
<startPage>71</startPage>
<endPage>74</endPage>
<doi>10.12691/ajmcr-9-1-18</doi>
<publisherRecordId>AJMCR20219118</publisherRecordId>
<documentType>article</documentType>
<title language="eng">Adult Large Cell/Anaplastic Medulloblastoma with Myogenic Differentiation: Case Report with Molecular Analysis</title>
<authors>
<author>
<name>Simin Laiq</name>
<email>siminlaiq@hotmail.com</email>
<affiliationId>1</affiliationId>
</author>
<author>
<name>Jaragh M</name>
<affiliationId>2</affiliationId>
</author>
<author>
<name>Ginsberg H</name>
<affiliationId>3</affiliationId>
</author>
<author>
<name>David G Munoz</name>
<affiliationId>3</affiliationId>
</author>

</authors>
<affiliationsList>
<affiliationName affiliationId="1">Histopathology Department, Directorate General of Khoula Hospital, Muscat, Oman</affiliationName>
<affiliationName affiliationId="2">Division of Pathology, St. Michael¡¯s Hospital, Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada</affiliationName>
<affiliationName affiliationId="3">Division of Neurosurgery, St. Michael¡¯s Hospital, Department of Surgery, Toronto, Ontario, Canada</affiliationName>

</affiliationsList>
<abstract language="eng">Medulloblastoma with myogenic differentiation (MMD), previously termed medullomyoblastoma, is a distinctive subtype of medulloblastoma. It is an uncommon neoplasm in children and very rare in adults, with oldest reported case being 49-years of age. We present a case of large cell/anaplastic medulloblastoma with myogenic differentiation arising in the right cerebellar hemisphere of a 54-year-old man treated by surgical resection and radiotherapy. Despite C-MYC amplification in the tumor, he survived tumor-free for nearly 2 years (726 days), which greatly exceeded the expected total survival. His death was attributed to complications of treatment rather than recurrence.</abstract>
<fullTextUrl format="pdf">http://pubs.sciepub.com/ajmcr/9/1/18/ajmcr-9-1-18.pdf</fullTextUrl>
<keywords language="eng"><keyword>Large cell/anaplastic medulloblastoma with myogenic differentiation</keyword>
<keyword>medullomyoblastoma</keyword>
<keyword>cerebellum</keyword>
<keyword>adult</keyword>
<keyword>C-MYC amplification</keyword>
</keywords>
</record>
</records>
